menu
    • menu

    Company profile for Eidos Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our product candidate, AG10, is an orally-administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatmen...
    Eidos Therapeutics is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our product candidate, AG10, is an orally-administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to slow the progression of ATTR diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eidos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    101 Montgomery St, STE 2550\nSan Francisco, California 94101
    Telephone
    Telephone
    415-887-1471
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eidostx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma & Eidos
    Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma & Eidos

    04 Jan 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/?s=79

    BIOSPACE
    04 Jan 2021
    Share Share
    BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
    BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement

    06 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/05/2103406/0/en/BridgeBio-Pharma-and-Eidos-Therapeutics-Announce-Merger-Agreement.html

    GLOBENEWSWIRE
    06 Oct 2020
    Share Share
    Eidos Therapeutics Appoints Industry Leaders With Significant DevelopmenT
    Eidos Therapeutics Appoints Industry Leaders With Significant DevelopmenT

    07 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/07/2075222/0/en/Eidos-Therapeutics-Appoints-Industry-Leaders-With-Significant-Development-and-Commercial-Expertise-to-Board-of-Directors.html

    GLOBENEWSWIRE
    07 Aug 2020
    Share Share
    BridgeBio scraps plan to buy Eidos after bids rebuffed
    BridgeBio scraps plan to buy Eidos after bids rebuffed

    15 Oct 2019

    // N.P.Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bridgebio-scraps-plan-to-buy-eidos-after-bids-rebuffed

    N.P.Taylor FIERCE BIOTECH
    15 Oct 2019
    Share Share
    Plotting toe-to-toe with Pfizer, Eidos plans score in PhIII ATTR-CM study
    Plotting toe-to-toe with Pfizer, Eidos plans score in PhIII ATTR-CM study

    28 Feb 2019

    // John Carroll ENDPTS

    https://endpts.com/plotting-to-go-toe-to-toe-with-heavyweight-pfizer-little-eidos-plans-quick-score-in-phiii-attr-cm-study/

    John Carroll ENDPTS
    28 Feb 2019
    Share Share
    EU green light for Cimzia to treat psoriasis
    EU green light for Cimzia to treat psoriasis

    03 Jul 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/eu_green_light_for_cimzia_to_treat_psoriasis_1243024

    Selina McKee PHARMA TIMES
    03 Jul 2018
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search